{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:43:30Z","timestamp":1781102610666,"version":"3.54.1"},"reference-count":56,"publisher":"National Academy of Sciences","issue":"34","license":[{"start":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:00:00Z","timestamp":1470787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.pnas.org\/preview_site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL121386-01A1"],"award-info":[{"award-number":["1R01HL121386-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["9P41EB015871-26A1"],"award-info":[{"award-number":["9P41EB015871-26A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["5R01NS051320"],"award-info":[{"award-number":["5R01NS051320"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["4R44EB012415"],"award-info":[{"award-number":["4R44EB012415"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-0939511"],"award-info":[{"award-number":["CBET-0939511"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DP3DK101024-01"],"award-info":[{"award-number":["DP3DK101024-01"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001474","name":"Singapore-MIT Alliance for Research and Technology Centre","doi-asserted-by":"publisher","award":["BioSyM IRG"],"award-info":[{"award-number":["BioSyM IRG"]}],"id":[{"id":"10.13039\/501100001474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001474","name":"Singapore-MIT Alliance for Research and Technology Centre","doi-asserted-by":"publisher","award":["Infectious Dieases IRG"],"award-info":[{"award-number":["Infectious Dieases IRG"]}],"id":[{"id":"10.13039\/501100001474","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2016,8,23]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>There exists a critical need for developing biomarkers reflecting clinical outcomes and for evaluating the effectiveness of treatments for sickle cell disease patients. Prior attempts to find such patient-specific markers have mostly relied upon chemical biomarkers or biophysical properties at hypoxia with limited success. We introduce unique biomarkers based on characterization of cellular biophysical properties at normoxia and show that these markers correlate sensitively with treatment using hydroxyurea (HU), the only US Food and Drug Administration (FDA)-approved drug for sickle cell disease patients. Our unique choice of cellular biophysical markers strongly correlates with mean cellular volume rather than fetal hemoglobin level, which provides insights into possible mechanisms through which HU treatment results in beneficial clinical outcomes.<\/jats:p>","DOI":"10.1073\/pnas.1610435113","type":"journal-article","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T23:34:15Z","timestamp":1470872055000},"page":"9527-9532","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":36,"title":["Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease"],"prefix":"10.1073","volume":"113","author":[{"given":"Poorya","family":"Hosseini","sequence":"first","affiliation":[{"name":"Laser Biomedical Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139;"},{"name":"Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;"},{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabia Z.","family":"Abidi","sequence":"additional","affiliation":[{"name":"Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Ocean and Mechanical Engineering, Florida Atlantic University, Boca Raton, FL 33431;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Papageorgiou","sequence":"additional","affiliation":[{"name":"Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngwoon","family":"Choi","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering, Korea University, Seoul 136-701, Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongKeun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Physics, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Systems Biology, Harvard Medical School, Boston, MA 02115;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\u2013Oncology, University of Pittsburgh, Pittsburgh, PA 15261;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subra","family":"Suresh","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213;"},{"name":"Department of Materials Science and Engineering, Carnegie Mellon University, Pittsburgh, PA 15213;"},{"name":"Department of Computational Biology, Carnegie Mellon University, Pittsburgh, PA 15213"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Dao","sequence":"additional","affiliation":[{"name":"Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Yaqoob","sequence":"additional","affiliation":[{"name":"Laser Biomedical Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T. C.","family":"So","sequence":"additional","affiliation":[{"name":"Laser Biomedical Research Center, Massachusetts Institute of Technology, Cambridge, MA 02139;"},{"name":"Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;"},{"name":"Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2016,8,10]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"crossref","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators (2015) Global regional and national age-sex specific all-cause and cause-specific mortality for 240 causes of death 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 385(9963):117\u2013171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/180326a0"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3233(08)60287-9"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1010013108"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7539154"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505183322001"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.12.4864"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-626259"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.3905"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199008093230602"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2978"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02040.x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-257444"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12070"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301143280201"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-409524"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-131762"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.506121"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-221333"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12323"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25608"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.10517"},{"key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up","volume":"85","author":"Steinberg MH","year":"2010","unstructured":"MH Steinberg, , The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. Am J Hematol; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients\u2019 Follow-Up 85, 403\u2013408 (2010).","journal-title":"Am J Hematol"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct0708272"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830140412"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-078188"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V65.1.183.183"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107043250103"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002738"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707122105"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1364\/OL.31.000775"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909533107"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0806100105"},{"key":"e_1_3_3_34_2","first-page":"30","article-title":"Cell heterogeneity in sickle cell disease: Quantitation of the erythrocyte density profile","volume":"106","author":"Rodgers GP","year":"1985","unstructured":"GP Rodgers, AN Schechter, CT Noguchi, Cell heterogeneity in sickle cell disease: Quantitation of the erythrocyte density profile. J Lab Clin Med 106, 30\u201337 (1985).","journal-title":"J Lab Clin Med"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414739111"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.2.214.214"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2012.07.011"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevE.77.031921"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(96)79239-1"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(89)73003-2"},{"key":"e_1_3_3_41_2","first-page":"52","article-title":"Membrane abnormalities of irreversibly sickled cells","volume":"16","author":"Eaton JW","year":"1979","unstructured":"JW Eaton, HS Jacob, JG White, Membrane abnormalities of irreversibly sickled cells. Semin Hematol 16, 52\u201364 (1979).","journal-title":"Semin Hematol"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109650"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-161166"},{"key":"e_1_3_3_44_2","first-page":"225","article-title":"The influence of membrane skeleton on red cell deformability, membrane material properties, and shape","volume":"20","author":"Mohandas N","year":"1983","unstructured":"N Mohandas, JA Chasis, SB Shohet, The influence of membrane skeleton on red cell deformability, membrane material properties, and shape. Semin Hematol 20, 225\u2013242 (1983).","journal-title":"Semin Hematol"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198404053101401"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2013.227"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmat1001"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1117\/1.3556717"},{"key":"e_1_3_3_49_2","first-page":"157","article-title":"The mean corpuscular volume and hydroxyurea in Brazilian patients with sickle cell anemia: A surrogate marker of compliance","volume":"4","author":"Queiroz AMM","year":"2013","unstructured":"AMM Queiroz, The mean corpuscular volume and hydroxyurea in Brazilian patients with sickle cell anemia: A surrogate marker of compliance. J Blood Disord Transfus 4, 157 (2013).","journal-title":"J Blood Disord Transfus"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424111112"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-559054"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23128"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-15813-1"},{"key":"e_1_3_3_54_2","volume-title":"Quantitative Phase Imaging of Cells and Tissues","author":"Popescu G","year":"2011","unstructured":"G Popescu Quantitative Phase Imaging of Cells and Tissues (McGraw Hill Professional, New York, 2011)."},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1364\/AO.45.002838"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1051\/jphys:0197500360110103500"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1610435113","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1610435113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:04:17Z","timestamp":1749042257000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1610435113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,10]]},"references-count":56,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,8,23]]}},"alternative-id":["10.1073\/pnas.1610435113"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1610435113","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,10]]},"assertion":[{"value":"2016-08-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}